The Global Asthma Report 2022

Glossary

AAIP

Allergy and Asthma Institute Pakistan


ADF

Asthma Drug Facility


BiPAP

Bilevel positive airways pressure


CME

Continued medical education


CMSs

Central medical stores


COPD

Chronic obstructive pulmonary disease


COVID-19

Coronavirus disease 2019


CPAP

Continuous positive airways pressure


CRD

Chronic respiratory diseases


DALYs

Disability adjusted life years


DOTS

Directly observed treatment, short-course


ED

Emergency Department


EML

Essential Medicines List


EMRO

Eastern Mediterranean Region


FIRS

Forum of International Respiratory Societies


GAAPP

Global Allergy and Airways Patient Platform


GAN

Global Asthma Network


GAR

Global Asthma Report


GARD

Global Alliance against Chronic Respiratory Diseases


GBD

Global Burden of Disease


GEMA

Guía Española para el Manejo del Asma


GINA

Global Initiative for Asthma


GOLD

Global Initiative for Obstructive Lung Diseases


HCC

Healthy Caribbean Coalition


HDI

Human Development Index


ICS

Inhaled corticosteroids


ICS+LABA

Combinations of ICS and LABA


IMSS

Instituto Méxicano de Seguro Social


INSABI

National Instituto de Salud para el Bienestar


ISAA

Iranian Society of Asthma and Allergy


ISAAC

International Study of Asthma and Allergies in Childhood


ISSSTE

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado


KSA

Kingdom of Saudi Arabia


LABA

Long-acting β2-agonist


LMICs

Low- and middle-income countries


LTRA

Leukotriene receptor antagonists


MDI

Metered dose inhaler


MHE

Ministry of Higher Education


MIA

Manejo Integral del Asma


MOH

Ministry of Health


NACP

National Asthma Control Program


NCD

Non-communicable disease


NGOs

Non-governmental organisations


NO2

Nitrogen dioxide


NRAD

National Review of Asthma Deaths


NZ

New Zealand


OCS

Oral corticosteroids


OR

Odds ratios


oSABA

Oral SABA


PACK

Package of Care Kit


PAL

Practical Approach to Lung Disease


PATS

Pan African Thoracic Society


PEN

Package of essential non-communicable disease Interventions for primary health care


PHCs

Public Health Centres


PIPA

Children’s Asthma Prevention Program


PM2.5

Particulate matter 2.5 microns


PTLD

Post-tuberculosis lung disease


r

Rank correlation


RBM

Roll Back Malaria


SABA

Short-acting β2-agonists


SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2


SDG

Sustainable Development Goals


SINA

Saudi Initiative for Asthma


TB

Tuberculosis


The Union

International Union against Tuberculosis and Lung Disease


TRAP

Traffic related air pollution


WAO

World Allergy Organization


WHO

World Health Organization


YLD

Years lived with disability


YLL

Years of life lost


Next: References >

The global epidemic of NCDs is a major and growing challenge to development.

Next: References >